Mark is a neuroscientist and neurologist with experience in teleneurology and telestroke. He has spent over a decade exploring the use of new technology to improve stroke care.
We are a clinician-led team that believes a close collaboration between clinicians and engineers is essential to building technology that is effective for both patients and providers.
Senior Management
Omar is an engineer who worked in industry before obtaining his medical degree. He is experienced in managing multi-disciplinary teams and has spent the last 7+ years working at the intersection of stroke and AI.
In 20+ years in healthcare tech, Ben has served as CTO for 6 investor-backed companies, and is currently an Oxford University Med Device Expert in Residence.
Elizabeth is an occupational therapist specializing in stroke recovery. Her clinical work along with her technology marketing experience help her present Syntrillo's platform in an accessible way to stroke survivors.
Brett has been CEO for two investor-backed SaaS companies. He brings his experience as an international tech M&A lawyer, a senior executive of a publicly-traded company, and a digital health investment banker. He has also been a board member of six investor backed companies.
Board of Directors
Mark is a neuroscientist and neurologist with experience in teleneurology and telestroke. He has spent over a decade exploring the use of new technology to improve stroke care.
Omar is an engineer who worked in industry before obtaining his medical degree. He is experienced in managing multi-disciplinary teams and has spent the last 7+ years working at the intersection of stroke and AI.
Brett has been CEO for two investor-backed SaaS companies. He brings his experience as an international tech M&A lawyer, a senior executive of a publicly-traded company, and a digital health investment banker. He has also been a board member of six investor backed companies.
Snehal received MD/JD from Columbia and was a clinical fellow and Fulbright scholar at the Harvard Medical School. Co-Founder and CEO of MyDoc - chronic disease management platform with a successful exit in 2022.
Syntrillo investor and the Chairman of GaitQ, AI and med device company transforming the management of Parkinson's disease. Founding partner of Fundsmith, a retail fund management business that he helped grow to +40B GBP AUM.
The full team